Keep Sonic under the microscope

The medical diagnostics company is well positioned to deliver shareholders a healthy return.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sonic Healthcare (ASX: SHL) is a company worth keeping an eye out for as a buying opportunity. Despite its share price being rather buoyant in the past month, it's bounced around enough recently to suggest there could be a good time to get on board. And there's every reason to believe in its long-term future.

Sonic was resonating well along with other healthcare and biotech stocks in the heady days before 2008, but it's only now retouching the highs revisited just once since then. On May 15 it made a 52-week high of $14.94 before a couple of retreats down to $14.11 yesterday — around the low- to mid-$13.00s, Sonic will look a more solid prospect.

Optimism for it as a worthy contender for your portfolio can be based on a number of factors: first, it's a mature defensive stock in growing sector; second, it earns about half its income from overseas, so it is well exposed to further falls in the Aussie dollar. Both in Europe and the United States the company aims for cost and service rationalisation with bolt-on acquistions.

However, developments at home may be just as good a reason to think Sonic can do well: the prospective change in government will increase calls to save costs with greater outsourcing of public pathology services; and there will be increased pressure to support companies earning overseas incomes, perhaps with taxation incentives like perhaps changing franking rules.

Responding to a call for just that from ANZ (ASX: NAB) chief executive Mike Smith, Sonic finance director Chris Wilks recently intimated it had little to do with the company's reduction in credits from 100% to 45%. And he added that franking may be reduced even further.

Wilks quite correctly said such considerations shouldn't drive strategy or impede offshore expansion. But if a change like that did happen to occur … it wouldn't be exactly unwelcome either.

Foolish takeaway

Sonic Healthcare still looks overpriced at recent quotes. Morningside has an intrinsic value of $13 on it and being able to get it at anything near that price would seem to offer a lot of upside. Notwithstahding untoward news, it seems a good stock to buy on short-term price weakness.

If you're looking for a solid investment idea, click here now to get The Motley Fool's special FREE report, "3 Stocks For the Great Dividend Boom". The report lists the names, stock symbols, and full research for our three favourite income ideas, all completely free!

More reading

Motley Fool contributor Andrew Ballard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »